ReneSola Ltd (NYSE:SOL) Q4 2023 Earnings Call Transcript March 28, 2024 ReneSola Ltd misses on earnings expectations. Reported EPS is $-0.15 EPS, expectations were $-0.09. SOL isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, ladies and gentlemen, thank you […]
Operator: Hello, ladies and gentlemen, thank you for standing by for Emeren Group Limited’s Fourth Quarter and Full Year 2023 Earnings Conference Call.
Closed Antares Pharma Acquisition, Accelerating High Growth Drug Delivery Leadership and Projected to be Accretive to Revenue for Full Year 2022 Second Quarter.
HALOZYME REPORTS SECOND QUARTER 2022 FINANCIAL AND OPERATING RESULTS marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Amgen (NASDAQ: AMGN) today announced financial results for the first quarter of 2022. Key results include: Total revenues increased 6% to $6.2.